Status:
UNKNOWN
Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinoma
Lead Sponsor:
Centre Henri Becquerel
Conditions:
Oesophageal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The poor prognosis in the early-stage of oesophageal carcinoma cancer is due to potential worsening of the disease (local relapse, metastasis), to insufficient efficacy and toxicity of actual treatmen...
Eligibility Criteria
Inclusion
- Carcinoma épidermoïde of the oesophagus histologically proved, UICC Stage II B, III or IVa (TNM on 2002)
- Decision of treatment by radio concomitant chemotherapy (radiotherapy in classic spreading of 50Gy associated with a platinum chemotherapy.
Exclusion
- Presence of a second evolutionary cancer in the previous three years
- index of performance OMS \> 2
- Patients badly balanced diabetics
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00934505
Start Date
May 1 2009
End Date
April 1 2014
Last Update
May 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CLCC H.Becquerel
Rouen, Haute Normandie, France, 76000